Drägerwerk AG & Co. KGaA: management transactions · Germany · BaFin

About Drägerwerk AG & Co. KGaA

Drägerwerk AG & Co. KGaA is a German industrial group focused on medical technology and safety technology. Listed on Xetra/Frankfurt (DAX/MDAX/SDAX) in Germany, the company has long been a leading provider of equipment and systems used in hospitals, emergency services, fire brigades, industrial sites, mining, and other hazardous environments. Founded in Lübeck, Germany, in 1889, Dräger has remained rooted in a family-business tradition while evolving into an international listed group with a strong operational base and a broad global commercial footprint. The group is organized around two core segments. The Medical division provides mission-critical solutions for intensive care and operating rooms, including ventilators, anesthesia machines, patient monitoring systems, hospital infrastructure, and related consumables and accessories. The Safety division develops personal protective equipment, gas detection systems, respiratory protection, engineered safety solutions, and instruments used to manage industrial risks. This two-pillar structure gives Dräger a balanced profile: resilient because many products are essential, but still exposed to hospital investment cycles, industrial capex, and customer spending patterns. From a competitive standpoint, Dräger benefits from a strong brand, an installed base of systems, and a reputation for engineering quality. The company increasingly emphasizes integrated solutions, connected devices, software-enabled workflows, and service contracts, which support customer stickiness and recurring revenue from consumables, maintenance, and services. Geographically, Dräger is globally diversified, operating in more than 190 countries and maintaining sales and service companies in around 50 countries, with the EMEA, Americas, and APAC regions forming the main commercial pillars. Recent business updates point to healthy operational momentum. In 2025, Dräger reported higher order intake across both divisions, with particularly strong demand for ventilators, anesthesia machines, services, and consumables in Medical, and for engineered solutions, gas detection, respiratory protection, and personal protection products in Safety. The company also indicated continued sales growth and improved earnings for fiscal 2025. For investors, Drägerwerk combines German industrial know-how, global diversification, and exposure to long-term structural drivers such as demographic ageing, workplace safety, and healthcare spending.